ANI Pharmaceuticals (ANIP) EV/EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EV/EBITDA | ? | 14.0 | 18.4 | 52.1 | 28.0 | 9.94 | 12.2 | ||
Changes by years, y/y, % | +44% | +31% | +183% | -46% | -64% | +0.3% |
ANI Pharmaceuticals. EV/EBITDA
ANI Pharmaceuticals. EV/EBITDA, changes, %
ANI Pharmaceuticals (ANIP) EV/EBITDA US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
EV/EBITDA | ? | 12.2 | 11.4 | 10.5 | 12.4 | 12.4 | 12.2 | |
Changes by years, y/y, % | -176% | -155% | -61% | -9% | +2% | |||
Changes by quarters, q/q, % | -11% | -7% | -8% | +19% | 0% |